Standard vs High-Dose Trivalent Inactivated Flu Vaccine in Adult Hematopoetic Stem Cell Transplant (HSCT) Recipients

Clinical trial NCT01215734 · COMPLETED

Trial details

NCT number: NCT01215734
Sponsor: Vanderbilt-Ingram Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Adult Stem Cell Hematopoetic Transplant

Start date: 2010-10-01
Primary completion: 2012-04-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.